Pluri (PLUR) Capital Expenditures (2010 - 2025)
Pluri (PLUR) reported Capital Expenditures of $447000.0 for Q4 2025, up 299.11% year-over-year from $112000.0 in Q4 2024, and up 285.34% quarter-over-quarter from $116000.0 in Q3 2025.
Pluri (PLUR) Capital Expenditures (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Capital Expenditures data on file, last reported at $447000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at $447000.0, up 299.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.9 million (up 344.15% YoY), and the FY2025 annual result was $1.6 million, up 400.93% from the prior year.
- Capital Expenditures advanced to $447000.0 in Q4 2025 per PLUR's latest filing, from $116000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $721000.0 in Q2 2025 and troughed at $10000.0 in Q2 2024.
- A 5-year average of $160600.0 and a median of $100000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures tumbled 89.69% in 2024, then jumped 7110.0% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $29000.0 in 2021, then jumped by 134.48% to $68000.0 in 2022, then jumped by 77.94% to $121000.0 in 2023, then retreated by 7.44% to $112000.0 in 2024, then jumped by 299.11% to $447000.0 in 2025.
- Business Quant data shows PLUR's Capital Expenditures at $447000.0 in Q4 2025, $116000.0 in Q3 2025, and $721000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 447,000.00 |
| Dec 31, 2025 | 447,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 721,000.00 |
| Jun 30, 2025 | 721,000.00 |
| Mar 31, 2025 | 577,000.00 |
| Mar 31, 2025 | 577,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Dec 31, 2024 | 112,000.00 |
| Sep 30, 2024 | 208,000.00 |
| Sep 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Sep 30, 2023 | 103,000.00 |